West Oak Capital’s LeMaitre Vascular LMAT Stock Holding History

West Oak Capital’s Portfolio LMAT Stock Details LMAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-500	Closed	-$42K	–	309
2025 Q1	$42K	Hold	500	–	–	0.02%	180
2024 Q4	$46.1K	Hold	500	–	–	0.02%	181
2024 Q3	$46.4K	Sell	500 -200	-29%	-$17.3K	0.01%	186
2024 Q2	$57.6K	Buy	+700	New	+$51.4K	0.02%	176

Other funds holding LMAT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CCM

Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return

GCM

Geneva Capital Management Milwaukee, Wisconsin $4.36B AUM 17.81% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.58B AUM 51% 1-Year Est. Return

West Oak Capital's LMAT Position: Q2 2025 in Review

West Oak Capital sold out of LeMaitre Vascular (LMAT) in Q2 2025, closing a stake of 500 shares — an estimated $42K sold.

West Oak Capital first reported a position in LMAT in Q2 2024 and held it in 4 quarters. The position peaked at $57.6K in Q2 2024. 283 funds tracked by Wall St. Rank hold LMAT as of Q2 2025.

West Oak Capital reported no remaining LeMaitre Vascular position as of Q2 2025 after selling out during the quarter.
West Oak Capital sold 500 LeMaitre Vascular shares in Q2 2025, an estimated $42K.
West Oak Capital first reported a position in LeMaitre Vascular in Q2 2024 and held it in 4 quarters.
West Oak Capital's LeMaitre Vascular position peaked at $57.6K in Q2 2024.
283 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2025.

Based on West Oak Capital's 13F filing for Q2 2025, filed 15 Jul 2025.